All In Biotech

Drug Trial Radar · NCT00519246

Comparison of Pain Therapeutic Effects After Benign Mastectomy

Clinical Comparison of Postoperative Pain Therapeutic Effects After Benign Mastectomy

Last checked: Nov 19, 2026Latest source record: Mar 31, 2009 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 2,000 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

2,000

Actual

Start

Feb 2007

Primary completion

Dec 2007

Study completion Dec 2007

Sponsor

Lead sponsor
Nanjing Medical UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Aug 22, 2007

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
Female only, from 18 years, up to 64 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

With the incremental trend of benign breast tumor, the surgical process of mastectomy was proceeded too much every day, especially in the Maternal Health Care Hospital, but whether the investigators can find another way to relieve the postoperative pain after such an operation is still unknown. The investigators hypothesized that the pain from the relatively small surgery may not be significant compared to different treatments, even if no drug was delivered to them. The investigators are enrolling patients who underwent mastectomy from benign breast tumor, and are observing the analgesic effects of different drugs.

Conditions

  • Pain, Postoperative
  • Mastectomy

Interventions

  • SalineDrug

    Saline 5 ml administrated intravenously

  • OpioidDrug

    Butorphanol tartrate 1 mg i.v.

  • OpioidDrug

    Butorphanol Tartrate 2 mg i.v.

  • NSAIDDrug

    Flurbiprofen Axetil 50 mg i.v.

  • NSAIDDrug

    Flurbiprofen Axetil 100 mg i.v.

  • OpioidDrug

    Tramadol Hydrochloride 10 mg i.v.

  • OpioidDrug

    Tramadol Hydrochloride 20 mg i.v.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Visual analog scale (VAS) rating of painTime frame: 0-24h after surgeries

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Nanjing Maternal and Child Care Hospital

    Nanjing, Jiangsu, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.